Current Overview of CDKL-5 Deficiency Disorder Treatment

被引：3

作者：

Dell'Isola, Giovanni Battista ^{[1
]}

Portwood, Katherin Elizabeth ^{[2
]}

Consing, Kirsten ^{[2
]}

Fattorusso, Antonella ^{[1
]}

Bartocci, Arnaldo ^{[3
]}

Ferrara, Pietro ^{[4
]}

Di Cara, Giuseppe ^{[1
]}

Verrotti, Alberto ^{[1
]}

Lodolo, Mauro ^{[2
]}

机构：

[1] Univ Perugia, Dept Pediat, I-06129 Perugia, Italy

[2] Univ Florida, Shands Childrens Hosp, Dept Child Neurol, Gainesville, FL 32608 USA

[3] Villa Margher, Neurophysipathol Serv, I-01027 Montefiascone, Italy

[4] Campus Biomed Univ, Pediat Unit, Rome, Italy

来源：

PEDIATRIC REPORTS | 2024年 / 16卷 / 01期

关键词：

VAGUS NERVE-STIMULATION; KETOGENIC DIET; FUNCTIONAL ABILITIES; REFRACTORY EPILEPSY; EFFICACY; CHILDREN;

D O I：

10.3390/pediatric16010002

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：21 / 25

页数：5

共 29 条

[1]

Amin S, 2017, HIPPOKRATIA, V21, P130

[2] Amelioration of intractable epilepsy by adjunct vagus nerve stimulation therapy in a girl with a CDKL5 mutation [J].

Baba, Shimpei ;

Sugawara, Yuji ;

Moriyama, Kengo ;

Inaji, Motoki ;

Maehara, Taketoshi ;

Yamamoto, Toshiyuki ;

Morio, Tomohiro .

BRAIN & DEVELOPMENT, 2017, 39 (04) :341-344

[3] CDKL5-Related Disorders: From Clinical Description to Molecular Genetics [J].

Bahi-Buisson, N. ;

Bienvenu, T. .

MOLECULAR SYNDROMOLOGY, 2011, 2 (3-5) :137-152

[4] Fenfluramine for the Treatment of Dravet Syndrome and Lennox-Gastaut Syndrome [J].

Balagura, Ganna ;

Cacciatore, Marta ;

Grasso, Eleonora A. ;

Striano, Pasquale ;

Verrotti, Alberto .

CNS DRUGS, 2020, 34 (10) :1001-1007

[5] CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development [J].

Demarest, Scott T. ;

Olson, Heather E. ;

Moss, Angela ;

Pestana-Knight, Elia ;

Zhang, Xiaoming ;

Parikh, Sumit ;

Swanson, Lindsay C. ;

Riley, Katherine D. ;

Bazin, Grace A. ;

Angione, Katie ;

Niestroj, Lisa-Marie ;

Lai, Dennis ;

Juarez-Colunga, Elizabeth ;

Benke, Tim A. .

EPILEPSIA, 2019, 60 (08) :1733-1742

[6] Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder [J].

Devinsky, Orrin ;

King, LaToya ;

Schwartz, Danielle ;

Conway, Erin ;

Price, Dana .

EPILEPSIA, 2021, 62 (07) :E98-E102

[7] Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes [J].

Devinsky, Orrin ;

Verducci, Chloe ;

Thiele, Elizabeth A. ;

Laux, Linda C. ;

Patel, Anup D. ;

Filloux, Francis ;

Szaflarski, Jerzy P. ;

Wilfong, Angus ;

Clark, Gary D. ;

Park, Yong D. ;

Seltzer, Laurie E. ;

Bebin, E. Martina ;

Flamini, Robert ;

Wechsler, Robert T. ;

Friedman, Daniel .

EPILEPSY & BEHAVIOR, 2018, 86 :131-137

[8] Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine [J].

Dini, Gianluca ;

Tulli, Eleonora ;

Dell'Isola, Giovanni Battista ;

Mencaroni, Elisabetta ;

Di Cara, Giuseppe ;

Striano, Pasquale ;

Verrotti, Alberto .

FRONTIERS IN PHARMACOLOGY, 2022, 13

[9] Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response A review [J].

Englot, Dario J. ;

Chang, Edward F. ;

Auguste, Kurtis I. .

JOURNAL OF NEUROSURGERY, 2011, 115 (06) :1248-1255

[10] Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder [J].

Fehr, Stephanie ;

Wong, Kingsley ;

Chin, Richard ;

Williams, Simon ;

de Klerk, Nick ;

Forbes, David ;

Krishnaraj, Rahul ;

Christodoulou, John ;

Downs, Jenny ;

Leonard, Helen .

NEUROLOGY, 2016, 87 (21) :2206-2213

← 1 2 3 →